From Practice-Changing Data to Future Innovation, Patient Outcome
Sep 13, 2024 — The ESMO Congress 2024 showcases the latest advances in cancer treatment, diagnosis and prevention, from immunotherapy to artificial intelligence. Learn about the practice-changing data, future directions and wellbeing of oncology professionals at the flagship event of the European Society for Medical Oncology.
ESMO Congress 2024
Sep 13, 2024 — The ESMO Congress 2024 is a global platform for oncology professionals and stakeholders to share the latest data and education. It will take place in person and online from 13-17 September 2024 in Barcelona, Spain.
ESMO 2024 Press Conference
Sep 13, 2024 — The ESMO Congress 2024 will hold a press conference to introduce and discuss the “Eyes to the Future” Presidential Symposium 3, that will be presenting prominent approaches that have the potential to become increasingly effective and influential components of cancer treatment in the (near) future.
Promising antitumour activity for emerging targets - dailyreporter.esmo…
Sep 16, 2024 — At the ESMO Congress 2024 (Barcelona, 13–17 September), some early-phase trials described promising strategies to target emerging actionable mutations in different solid tumours, such as methylthioadenosine phosphorylase (MTAP) deletion, KRAS G12D mutation, and CDK4 and 2, reporting good tolerability and antitumour activity for novel targeted ...
Latest News - ESMO Daily Reporter
Read the latest news on studies presented at ESMO congresses and other hot topics in oncology. Find out about advances in melanoma, lung cancer, breast cancer, gastrointestinal cancers, sarcoma, and more.
ESMO Congress 2024 - Daily Reporter
Find out the latest news and updates from the ESMO Congress 2024, the leading European event in oncology. Explore the topics, tumour sites, and studies presented by experts and researchers in Barcelona, Spain.
ESMO 2024: breaking news and abstracts - Oncology Central
With ESMO 2024 (13–17 September, Barcelona, Spain) wrapped up, we're excited to bring you the latest breaking news, late-breaking abstracts and highlights from this year's congress. From groundbreaking trials to innovative research developments, this collection captures the most impactful moments.
Key Advances in Oncology: Top Highlights From ESMO 2024
Sep 18, 2024 — Learn about the latest breakthroughs in cancer research and clinical practice from the 2024 ESMO Congress. Find out the results of trials on nivolumab, adagrasib, T-DXd, pembrolizumab, lenvatinib, belzutifan, Dato-DXd, fianlimab, zipalertinib, radium-223, and more.
ESMO 2024: For T-cell target antigens, lots to see, but what to …
Sep 16, 2024 — Among the most profound results presented over the weekend at the European Society for Medical Oncology (ESMO) 2024 Congress were the 10-year data from the Checkmate-067 and Keynote-006 trials, the phase III trials that tested Opdivo (nivolumab, Bristol Myers Squibb Co.) and Keytruda (pembrolizumab, Merck & Co. Inc.) as first-line agents in ...
Breast Cancer Breakthroughs: 2024 ESMO Highlights
Oct 21, 2024 — The incredible pace of advancements in breast cancer therapeutics was again demonstrated at the 2024 European Society for Medical Oncology (ESMO) Congress. At the forefront of these advances were new data for several antibody-drug conjugates (ADCs) and molecular therapeutics.
- Some results have been removed